Jupiter Neurosciences, Inc. Common Stock (JUNS) Stock Price

JUNSStock

$5.17−95.04%52W

Market Cap$6.87M

P/E—

PEG Ratio—

Div yield—

Beta0.67

JUNS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-97.75%

Price vs S&P 500 (4W)-34.28%

VGM Score20.17

Book Value / Share (Quarterly)$0.13

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-67.55%

Cash Flow / Share (Quarterly)$-11.96

Price vs S&P 500 (YTD)-104.56%

Net Profit Margin (TTM)-11463.51%

EPS (TTM)$-14.56

10-Day Avg Trading Volume5.36M

EPS Excl Extra (TTM)$-14.56

EPS (Annual)$-18.73

ROI (Annual)-56.50%

Gross Margin (Annual)80.60%

Cash / Share (Quarterly)$4.89

ROA (Last FY)-155.37%

EBITD / Share (TTM)$-1.08

Operating Margin (TTM)-11796.74%

Cash Flow / Share (Annual)$-11.79

P/B Ratio80.47x

P/B Ratio (Quarterly)1067.68x

Net Income / Employee (Annual)$-1,729,000

Net Interest Coverage (TTM)-67.83x

ROA (TTM)-228.64%

EPS Incl Extra (Annual)$-18.73

Current Ratio (Annual)0.65x

Quick Ratio (Quarterly)0.48x

3-Month Avg Trading Volume0.73M

52-Week Price Return-95.04%

Revenue / Employee (TTM)$8,100

Tangible BV / Share (Quarterly)$-0.24

P/S Ratio (Annual)211.95x

Asset Turnover (Annual)0.00x

52-Week High$138.00

EPS Excl Extra (Annual)$-18.73

26-Week Price Return-86.50%

Quick Ratio (Annual)0.63x

13-Week Price Return-72.13%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)0.51x

Enterprise Value$7.08M

Revenue / Employee (Annual)$4,400

Pretax Margin (Annual)-39655.50%

Cash / Share (Annual)$8.25

3-Month Return Std Dev162.50%

Net Income / Employee (TTM)$-1,835,600

ROE (Last FY)-58.48%

Net Interest Coverage (Annual)-19.84x

EPS Basic Excl Extra (Annual)$-18.73

Receivables Turnover (TTM)0.05x

Total Debt / Equity (Quarterly)2.55x

EPS Incl Extra (TTM)$-14.56

Receivables Turnover (Annual)0.03x

ROI (TTM)-329.56%

P/S Ratio (TTM)114.23x

Revenue / Share (Annual)$0.05

Tangible BV / Share (Annual)$-0.23

Forward P/E1.15x

Price vs S&P 500 (52W)-113.35%

Year-to-Date Return-92.60%

5-Day Price Return11.86%

EPS Normalized (Annual)$-18.73

ROA (5Y Avg)-1228.96%

Net Profit Margin (Annual)-39655.50%

Month-to-Date Return-16.15%

EBITD / Share (Annual)$-19.30

Operating Margin (Annual)-40865.69%

LT Debt / Equity (Annual)0.00x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-14.56

P/B Ratio (Annual)84.90x

Pretax Margin (TTM)-11463.51%

Book Value / Share (Annual)$9.45

Price vs S&P 500 (13W)-74.93%

Beta0.67x

Revenue / Share (TTM)$0.09

ROE (TTM)-352.06%

52-Week Low$4.56

mGradeD

vgmGradeD

JUNS Earnings Surprise History

Q4 24-3.75est. -1.50

Q1 25-3.75est. -2.25

Q2 25-5.25est. -5.25

Q3 25-5.25est. -6.00

JUNS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
JUNSJupiter Neurosciences, Inc. Common Stock	—	—	D	$5.17
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Jupiter Neurosciences, Inc. Common Stock

Jupiter Neurosciences is a clinical-stage biopharmaceutical company developing a resveratrol-based therapeutic platform to address neuroinflammation in central nervous system diseases. Its lead candidate, JOTROL, targets conditions including Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.